BioTech Innovation and National Security Continuation Act

The BioTech Innovation and National Security Continuation Act, introduced in the 118th Congress on October 1, 2024, aims to advance biotechnology innovation while addressing national security concerns. The bill, designated as H.R. 9900, focuses on bolstering the intersection of biotech advancements and safeguarding national security interests. Specific provisions and directives within the bill include measures to enhance research and development in the biotechnology sector, promote collaboration between government agencies and private entities, and implement safeguards to protect critical biotech infrastructure. For further details and the complete text of the bill, the official PDF version can be accessed via the provided link.